SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-16-004875
Filing Date
2016-12-20
Accepted
2016-12-20 07:42:03
Documents
8
Period of Report
2016-12-19

Document Format Files

Seq Description Document Type Size
1 FORM 6-K merus6k.htm 6-K 7547
2 NEWS RELEASE DATED DECEMBER 14, 2016 ex991.htm EX-99.1 23326
3 AFS - SEPTEMBER 30, 2016 ex992.htm EX-99.2 808396
4 MDA - SEPTEMBER 30, 2016 ex993.htm EX-99.3 406237
5 GRAPHIC botgraphic.jpg GRAPHIC 5937
6 GRAPHIC meruslogo.jpg GRAPHIC 8449
7 GRAPHIC mnplogo.jpg GRAPHIC 3863
8 GRAPHIC mnpsig.jpg GRAPHIC 3032
  Complete submission text file 0001279569-16-004875.txt   1276636
Mailing Address 100 WELLINGTON ST. WEST SUITE 2110 P.O. BOX 151 TORONTO A6 M5K 1H1
Business Address 100 WELLINGTON ST. WEST SUITE 2110 P.O. BOX 151 TORONTO A6 M5K 1H1 416 593-3701
Merus Labs International Inc. (Filer) CIK: 0001031516 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 000-30082 | Film No.: 162060272
SIC: 2834 Pharmaceutical Preparations